Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 8/20 | 0.68 |
| ▸ | CES1 | P23141 | 8/20 | 0.68 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30013497 | 0.87 | CES2 (0.68) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL650572 | 0.87 | CES2 (0.68) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL2511292 | 0.86 | CES2 (0.65) | CES2CES1BCHELMNAMEN1 | |
| SCHEMBL30716847 | 0.85 | ALB (0.58) | CES2CES1BCHELMNAMEN1 | |
| SCHEMBL28137004 | 0.83 | CES2 (0.50) | CES2CES1BCHELMNAMEN1 | |
| SCHEMBL28868999 | 0.83 | CES2 (0.50) | CES2CES1BCHELMNAMEN1 | |
| SCHEMBL28956589 | 0.83 | CES2 (0.50) | CES2CES1BCHELMNAMEN1 | |
| SCHEMBL27428737 | 0.83 | CES2 (0.49) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL27913742 | 0.83 | CES2 (0.49) | CES2CES1LMNAMEN1KMT2A | |
| SCHEMBL8800486 | 0.82 | CES2 (0.49) | CES2CES1BCHELMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002067304-A1 | A METHOD OF FORMING RESIST PATTERNS IN A SEMICONDUCTOR DEVICE AND A SEMICONDUCTOR WASHING LIQUID USED IN SAID METHOD | HYON MAN-SOK (KR) | 2002-08-29 | — | — | WO | claimed |
| CN-215139804-U | Synthetic reaction device of 2,6 difluorobenzoic acid methyl ester | 江西华兴化工有限公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-112158831-A | Photoactive modified graphene and preparation method and application thereof | 胥彩虹 | 2021-01-01 | — | — | CN | disclosed |
| EP-3463723-A1 | SYNTHESIS OF ULTRA-THIN METAL NANOWIRES USING ORGANIC FREE RADICALS | The Regents of The University of California (US) | 2019-04-10 | — | — | EP | disclosed |
| CN-109475943-A | Superfine metal nano wire is synthesized with organic free radical | 加利福尼亚大学董事会 | 2019-03-15 | — | — | CN | disclosed |
| CN-108290925-A | Gelatinase inhibitor and application thereof | 艾普罗特斯公司 | 2018-07-17 | — | — | CN | disclosed |
| CN-107954851-A | A kind of synthetic method of medicine intermediate 2,4 difluorobenzene formic acid | 苏州盖德精细材料有限公司 | 2018-04-24 | — | — | CN | disclosed |
| US-9828339-B2 | Biphenyl derivatives and methods for preparing same | DONG-A ST CO., LTD (KR) | 2017-11-28 | — | — | US | disclosed |
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | DONG-A ST CO., LTD (KR) | 2016-06-23 | — | — | US | disclosed |
| US-20080045521-A1 | PHENYLALANINE DERIVATIVES | ASTRAZENECA AB (SE) | 2008-02-21 | — | — | US | disclosed |
| US-7317031-B2 | Substituted triazole diamine derivatives as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2008-01-08 | — | — | US | disclosed |
| US-20050182116-A1 | Substituted triazole diamine derivatives as kinase inhibitors | LIN RONGHUI (US) | 2005-08-18 | — | — | US | disclosed |
| US-6924302-B2 | Substituted triazole diamine derivatives as kinase inhibitors | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1549600-A1 | KETONES | AstraZeneca AB (SE) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004011410-A1 | CHEMICAL COMPOUNDS | ASTRAZENECA AB (SE) | 2004-02-05 | — | — | WO | disclosed |
| US-6359144-B1 | BIOSYNTHESIS; SCREENING | LION BIOSCIENCE AG (DE) | 2002-03-19 | — | — | US | disclosed |
| US-4176222-A | BY HEATING A BISPHENOL, DIHALOBENZENOID COMPOUND WITH SODIUM CARBONATE OR BICARBONATE AND A SECOND ALKALI METAL CARBONATE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045521-A1 | PHENYLALANINE DERIVATIVES | ITGB5, ITGB1, ITGA2B | CES2 4792/4885CES1 3194/4885BCHE 3939/4885 |
| US-20160176816-A1 | NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME | CHRM2, CHRM3, CHRM5 | CES2 3209/4885CES1 1441/4885BCHE 50/4885 |
| US-20050182116-A1 | Substituted triazole diamine derivatives as kinase inhibitors | MAP2K2, PRKDC, MAP2K3 | CES2 3344/4885CES1 2839/4885BCHE 4198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.